DBV Technologies | GJELD



Debt Endring Dato
Acadia Pharmaceuticals USD 0 0 2024-12
Alnylam Pharmaceuticals USD 1.02B 967K 2024-12
Amarin USD 0 0 2024-09
BioMarin Pharmaceutical USD 596.24M 1.61M 2024-12
DBV Technologies USD 0 0 2024-09
Halozyme Therapeutics USD 1.51B 1.64M 2024-12
Incyte USD 37.96M 5.81M 2024-12
Insmed USD 1.13B 147.86M 2024-12
Ionis Pharmaceuticals USD 1.25B 32.8M 2024-12
Neurocrine Biosciences USD 0 0 2024-12
PTC Therapeutics USD 2.39B 389K 2024-12
Sarepta Therapeutics USD 1.14B 90.44M 2024-12
Ultragenyx Pharmaceutical USD 0 0 2024-12
United Therapeutics USD 300M 100M 2024-12



DBV Technologies GJELD - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2025.